Dave Shelton

Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9

Javier Chaparro‐Riggers, Liang Hong, Rachel M. DeVay et al. · Journal of Biological Chemistry · 2012 · 165 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Generating Bispecific Human IgG1 and IgG2 Antibodies from Any Antibody Pair

Pavel Strop, Wei-Hsien Ho, Leila M. Boustany et al. · Journal of Molecular Biology · 2012 · 145 citations

Pharmacy, Immunology, Molecular Biology +16

RN927C, a Site-Specific Trop-2 Antibody–Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models

Pavel Strop, Thomas-Toan Tran, Magdalena Dorywalska et al. · Molecular Cancer Therapeutics · 2016 · 102 citations

Medicine, Oncology, Pharmacology +16

Mechanism of Action and In Vivo Efficacy of a Human-Derived Antibody against Staphylococcus aureus α-Hemolysin

Davide Foletti, Pavel Strop, Lee Shaughnessy et al. · Journal of Molecular Biology · 2013 · 91 citations

Pharmacy, Immunology, Pharmacology +13

Cigarette smoking and its risk factors among elementary school students in Beijing.

Bao‐Ping Zhu, M Liu, Dave Shelton et al. · American Journal of Public Health · 1996 · 88 citations · Full text

Public Health, Child Health, Preventive Medicine +15